- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1417
Companies which are more than 50% undervalued based on analyst price target.
1,417 companies
Cocrystal Pharma
Market Cap: US$16.0m
A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
COCP
US$1.52
7D
-5.0%
1Y
-12.1%
NeurAxis
Market Cap: US$15.7m
A medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
NRXS
US$2.00
7D
-13.8%
1Y
-38.3%
New Horizon Aircraft
Market Cap: US$15.7m
An aerospace original equipment manufacturer company, focuses on designing and developing hybrid electric vertical takeoff and landing (eVTOL) aircraft for the regional air mobility market in the Uinted States.
HOVR
US$0.49
7D
-5.2%
1Y
-75.6%
Unity Biotechnology
Market Cap: US$15.7m
A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.
UBX
US$0.91
7D
-18.4%
1Y
-40.3%
Banzai International
Market Cap: US$15.5m
A marketing technology company, provides data-driven marketing and sales solutions for various businesses in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
BNZI
US$1.00
7D
-5.9%
1Y
-94.1%
Cingulate
Market Cap: US$15.4m
A biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
CING
US$4.01
7D
-7.2%
1Y
-56.1%
Edesa Biotech
Market Cap: US$15.2m
A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.
EDSA
US$2.05
7D
-14.2%
1Y
-55.6%
Calidi Biotherapeutics
Market Cap: US$15.1m
A clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States.
CLDI
US$0.46
7D
-7.9%
1Y
-80.6%
Lifeward
Market Cap: US$14.6m
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
LFWD
US$1.37
7D
-2.8%
1Y
-72.8%
BioCardia
Market Cap: US$14.5m
A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.
BCDA
US$2.85
7D
6.3%
1Y
-52.0%
Equillium
Market Cap: US$14.3m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.
EQ
US$0.39
7D
-7.0%
1Y
-74.5%
Bolt Biotherapeutics
Market Cap: US$14.2m
A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.
BOLT
US$0.36
7D
1.3%
1Y
-71.6%
Moleculin Biotech
Market Cap: US$14.1m
A clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses.
MBRX
US$1.05
7D
1.9%
1Y
-77.9%
Allurion Technologies
Market Cap: US$14.1m
Focuses on ending obesity with a weight loss platform to treat people who are overweight.
ALUR
US$2.38
7D
2.1%
1Y
-95.1%
ECD Automotive Design
Market Cap: US$13.9m
Engages in the production and sale of customized Land Rover vehicles in the United States.
ECDA
US$0.35
7D
16.1%
1Y
-69.9%
BiomX
Market Cap: US$13.9m
A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.
PHGE
US$0.52
7D
-11.8%
1Y
-85.4%
Worksport
Market Cap: US$13.9m
Together with its subsidiary, designs and distributes truck tonneau covers in Canada and the United States.
WKSP
US$2.90
7D
-10.8%
1Y
-65.6%
Marker Therapeutics
Market Cap: US$13.7m
A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR
US$1.16
7D
-7.2%
1Y
-71.9%
BioRestorative Therapies
Market Cap: US$13.7m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.80
7D
-2.2%
1Y
31.4%
LiqTech International
Market Cap: US$13.5m
A clean technology company, engages in the development, design, production, marketing, and sale of automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LIQT
US$1.41
7D
-4.8%
1Y
-51.7%
Perfect Moment
Market Cap: US$13.5m
Owns and operates a fashion brand that offers ski, surf, and activewear collections under the brand name of Perfect Moment in the United States and the United Kingdom.
PMNT
US$0.85
7D
6.2%
1Y
-70.7%
Harvard Bioscience
Market Cap: US$13.5m
Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.
HBIO
US$0.32
7D
-9.4%
1Y
-91.1%
GeoVax Labs
Market Cap: US$13.4m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
GOVX
US$0.93
7D
-8.2%
1Y
-40.5%
Greenidge Generation Holdings
Market Cap: US$13.4m
Operates as an integrated cryptocurrency datacenter and power generation company.
GREE
US$1.00
7D
-9.4%
1Y
-60.0%
Flora Growth
Market Cap: US$13.3m
Engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide.
FLGC
US$0.68
7D
7.8%
1Y
-50.4%
Brand Engagement Network
Market Cap: US$13.3m
Provides conversational AI assistants.
BNAI
US$0.32
7D
-9.0%
1Y
-78.1%
Air Industries Group
Market Cap: US$13.1m
Engages in the design, manufacture, and sale of precision components and assemblies for defense and aerospace industry in the United States.
AIRI
US$3.50
7D
-3.3%
1Y
-45.2%
IN8bio
Market Cap: US$12.8m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.
INAB
US$0.16
7D
-7.1%
1Y
-84.4%
ProPhase Labs
Market Cap: US$12.7m
Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.
PRPH
US$0.30
7D
-8.4%
1Y
-94.0%
Cambium Networks
Market Cap: US$12.7m
Engages in the design, development, and manufacture of wireless broadband and Wi-Fi networking infrastructure solutions.
CMBM
US$0.45
7D
-0.6%
1Y
-87.5%
Hoth Therapeutics
Market Cap: US$12.5m
A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.
HOTH
US$0.95
7D
7.1%
1Y
-18.6%
NextCure
Market Cap: US$12.5m
A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
NXTC
US$0.45
7D
0.8%
1Y
-73.0%
Direct Digital Holdings
Market Cap: US$12.3m
Operates as an end-to-end full-service advertising and marketing platform.
DRCT
US$0.65
7D
-24.6%
1Y
-83.7%
Co-Diagnostics
Market Cap: US$12.2m
Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
CODX
US$0.34
7D
-7.6%
1Y
-69.4%
Dolphin Entertainment
Market Cap: US$12.2m
Operates as an entertainment marketing and production company in the United States.
DLPN
US$1.09
7D
-3.1%
1Y
-51.3%
Imunon
Market Cap: US$12.1m
A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.
IMNN
US$0.80
7D
-4.4%
1Y
-42.0%